The performance of companies tied to Sildenafil's history presents a intricate investment scenario . While the initial success generated substantial returns , generic competition have significantly diminished sales . Investing in associated pharmaceutical businesses now requires a careful assessment of patent safeguards, evolving medical shifts , a